Loading company…
Sky Pharma develops regenerative medicine and drugs for glaucoma and spinal injuries.
Founded in 2019 and based in Miyagi, Japan, Sky Pharma develops and distributes regenerative medicine using low molecular compounds. Its drug discovery work targets diseases and injuries including glaucoma and spinal injuries.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in